Xilio Therapeutics Inc (XLO)
NASDAQ
Fin d'année 31 Décembre 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -55.199 | -111.51 | -59.597 | -49.393 | -76.369 |
Return on Equity (%) | 117.271 | 97.897 | -148.421 | -60.618 | -107.253 |
Return on Invested Capital (%) | -82.057 | -233.985 | -77.568 | -59.382 | -111.358 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | -0.806 | 6.778 | 3.852 | 1.337 |
Earnings Per Share | N/A | -8.424 | -2.771 | -3.217 | -2.774 |
Cash Per Share | N/A | 2.935 | 7.239 | 4.39 | 1.623 |
Working Capital Per Share | N/A | -0.239 | 6.935 | 3.769 | 1.168 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | -8.424 | -2.771 | -3.217 | -2.774 |
EBITDA Per Share | N/A | -8.424 | -2.771 | -3.217 | -2.774 |
Free Cash Flow Per Share | N/A | -8.253 | -2.785 | -3.211 | -2.822 |
Fin d'année 31 Décembre 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | N/A | 6,56M | 27,36M | 27,43M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||||
Actions en circulation | 27,43M | N/A | N/A | N/A | N/A | 34,47M | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 41,23M |
Ratio cours/bénéfice | -0,59 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 1 |
Ratio prix/valeur comptable | 1,22 |
Rendement de dividende | - |
Actions en circulation | 43,96M |
Volume moyen (1 semaine) | 1,05M |
Volume moyen (1 mois) | 343,24k |
Variation sur 52 semaines | 78,81% |
Plus haut sur 52 semaines | 1,93 |
Plus bas sur 52 semaines | 0,49 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales